Model
Edge
Checkmate Pharmaceuticals Inc.
0001651431
Filing Type
8-K
Filing Date
5/30/2022
Updated
5/31/22, 3:16 AM
Filing
8-K
Earnings Release
Exhibits
8-K
Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws
EX-3.1
EXHIBIT 3.1
EX-3.2
EXHIBIT 3.2